FICO Analysts Cut Targets as Earnings Loom

Fair Isaac Corporation gained 5.7% this week to close at $815.31, a solid bounce that still leaves the stock down nearly 11% over the past month and trailing most of its closest peers, with correlated names like ROP and MNDY each up more than 14% and 17% respectively on the week.

The most striking feature of FICO's recent market life is not the price action but the analyst price-target reset. Every firm that has published on the name in October has cut its target, without exception, and the cuts have been deep. Mizuho came in on October 19 trimming to $1,063 from $1,344. RBC Capital dropped to $1,045 from $1,525 a few days earlier. Raymond James went from $1,750 to $1,230. Wells Fargo set a target of $800, below the current price. Bank of America went furthest, downgrading the rating to Neutral and halving its target to $700. The consensus sits at a mean target of around $1,007, implying roughly 23% upside from current levels on paper, but that figure reflects an average of targets that are themselves being revised down rapidly as earnings approach on November 4. The consensus rating is hold, with eight analysts there and four at outperform or better, and no upgrades in this cycle.

The bull case rests on the franchise durability of FICO Scores, where second-quarter revenue jumped 60% year on year to $475 million, operating margins expanded to 64.7%, and the software platform reported ARR growth of 49% with net retention at 109%. A $1.5 billion accelerated share repurchase, funded by a term loan, reinforces management's conviction. The bear case is more structural: if financial institutions pull back on scoring volumes during a credit slowdown, revenue concentration in Scores creates outsized downside. The FHFA's decision to allow VantageScore 4.0 for GSE-backed mortgages is a slow-burning competitive risk that could compress the multiple attached to the Scores franchise, which is where most of FICO's valuation lives. The trailing P/E is near 14.8x and the EPS momentum factor ranks in the 94th percentile on a 30-day basis, a tension between strong recent earnings revisions and a price level that has already given back a year's worth of gains.

Short positioning tells a different story from the analyst pessimism. Short interest at just under 9% of the free float is meaningful in absolute terms, and it rose sharply through October, climbing roughly 20% over the past month. That said, it has been essentially flat this week, edging down fractionally to around 2.1 million shares. Availability in the lending market is generous: roughly 1,285% of short interest is available to borrow, leaving ample room for new short positions to be established without any squeeze pressure. Cost to borrow has eased 17% over the past week to 0.39%, reinforcing that the borrow market is relaxed. The ORTEX short score sits at 48.8, near the midpoint, and has drifted lower through October, suggesting no meaningful escalation in short conviction despite the price decline.

Options traders have grown more cautious. The put/call ratio is at 0.95, running above its 20-day average of 0.85 by more than one standard deviation. That is not extreme by FICO's own history, where the 52-week high is 1.10, but the direction has been one-way: the PCR was below 0.70 in early October and has moved consistently higher since, coinciding with the round of analyst target cuts. Wikipedia pageview data from the ORTEX alt data layer flags an attention spike, with a retail-interest z-score of 2.49 against FICO's own 90-day history, suggesting the stock is drawing more casual scrutiny than usual ahead of the November 4 print.

FICO's earnings history sets a cautious frame. The two most recent quarterly results each produced sharp negative reactions: a 14.7% one-day fall at the end of July, extending to 18.3% over the following five days, and an 8.3% one-day decline at the subsequent print. Separately, ORTEX puts a 75% probability on FICO being added to the CRSP US Small index at the December 2026 quarterly review, which would require the stock to close above approximately $971, an 18% rally from current levels. If that addition were to occur, the associated tracker buying is estimated at around $275 million, or half a day's normal trading volume. The rank date for that decision is December 4.

With earnings eleven days out and the stock well below where most analysts set their targets before the recent revision cycle, the question going into the November 4 release is whether FICO's Scores pricing power held through the quarter or whether the macro and competitive pressures analysts are flagging have begun to show in the numbers.